Medicines labeled for the same conditions
Alternatives to lasmiditan
12 other medicines are given the same way (oral) and in the same FDA class as lasmiditan or labeled mainly for the same use (migraine); the others include 9 serotonin-1b and serotonin-1d receptor agonists and 3 calcitonin gene-related peptide receptor antagonists (FDA labels read October 8, 2026).
Which medicines are labeled for the same conditions as lasmiditan?
Migraine lists all 27 medicines labeled for it, by any route. Each row shows the conditions both labels name. They are listed as public records, not as substitutes: whether one can replace another depends on the person and is a prescriber's decision.
| Medicine and FDA class | Shared indication | Generic labelers (oral) | Pharmacy cost | Boxed warning | Shortage |
|---|---|---|---|---|---|
| Lasmiditan | this medicine | none listed | $88.77 per tablet 100 mg tablet | No | A presentation being discontinued |
| Sumatriptanserotonin-1b and serotonin-1d receptor agonist | Migraine | 22 labelers | $0.302 per tablet 50 mg tablet | No | No current entry |
| Rizatriptanserotonin-1b and serotonin-1d receptor agonist | Migraine | 25 labelers | $0.335 per tablet 10 mg tablet | No | No current entry |
| Zolmitriptanserotonin-1b and serotonin-1d receptor agonist | Migraine | 18 labelers | $1.02 per tablet 2.5 mg tablet | No | No current entry |
| Eletriptanserotonin-1b and serotonin-1d receptor agonist | Migraine | 10 labelers | $1.75 per tablet 40 mg tablet | No | No current entry |
| Naratriptanserotonin-1b and serotonin-1d receptor agonist | Migraine | 4 labelers | $1.08 per tablet 2.5 mg tablet | No | No current entry |
| Almotriptanserotonin-1b and serotonin-1d receptor agonist | Migraine | 3 labelers | $16.86 per tablet 12.5 mg tablet | No | No current entry |
| Naproxen and sumatriptanserotonin-1b and serotonin-1d receptor agonist | Migraine | 3 labelers | $10.46 per unit 85-500 mg | Yes | No current entry |
| Frovatriptanserotonin-1b and serotonin-1d receptor agonist | Migraine | 4 labelers | $2.72 per tablet 2.5 mg tablet | No | A presentation being discontinued |
| Ubrogepantcalcitonin gene-related peptide receptor antagonist | Migraine | none listed | $109.11 per tablet 100 mg tablet | No | No current entry |
| Atogepantcalcitonin gene-related peptide receptor antagonist | Migraine | none listed | $38.36 per tablet 10 mg tablet | No | No current entry |
| Rimegepantcalcitonin gene-related peptide receptor antagonist | Migraine | none listed | $128.67 per tablet 75 mg tablet | No | No current entry |
| Meloxicam and rizatriptanserotonin-1b and serotonin-1d receptor agonist | Migraine | none listed | $122.64 per tablet 20-10 mg tablet | Yes | No current entry |
Source: FDA drug labels (indications) via openFDA; FDA NDC Directory; CMS NADAC of October 7, 2026; FDA Drug Shortage Database (FDA files October 8, 2026)
What do pharmacies pay for each?
The headline NADAC price per unit of each medicine's most widely listed form; strengths differ, so compare like with like on each record.
Source: CMS National Average Drug Acquisition Cost (NADAC) survey, October 7, 2026: what retail pharmacies paid per unit; not a counter price
What next?
- Lasmiditan: the full record
- label, generics, price, shortages, recalls